Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:treprostinil
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:form |
dry powder inhaler
|
| gptkbp:hasDevelopmentCode |
gptkb:LIQ861
|
| https://www.w3.org/2000/01/rdf-schema#label |
LIQ861
|
| gptkbp:indication |
pulmonary arterial hypertension
|
| gptkbp:isBeingDevelopedBy |
gptkb:Liquidia_Technologies
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:therapeuticArea |
pulmonary arterial hypertension
|
| gptkbp:bfsParent |
gptkb:Liquidia_Technologies
|
| gptkbp:bfsLayer |
7
|